Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9,900
Closed -$735K 3183
2024
Q2
$735K Buy
9,900
+1,300
+15% +$97.4K 0.01% 1272
2024
Q1
$670K Buy
8,600
+3,800
+79% +$283K 0.01% 1369
2023
Q4
$343K Buy
4,800
+1,700
+55% +$118K ﹤0.01% 1873
2023
Q3
$215K Buy
+3,100
New +$234K ﹤0.01% 2263
2023
Q1
Sell
-11,300
Closed -$845K 2916
2022
Q4
$845K Buy
+11,300
New +$805K 0.03% 772
2020
Q1
Sell
-22,600
Closed -$1.18M 1758
2019
Q4
$1.18M Buy
+22,600
New +$1.13M 0.01% 963
2019
Q3
Sell
-10,200
Closed -$490K 2220
2019
Q2
$490K Buy
+10,200
New +$472K 0.01% 1129
2018
Q4
Sell
-6,500
Closed -$266K 2432
2018
Q3
$266K Sell
6,500
-39,600
-86% -$1.6M ﹤0.01% 1854
2018
Q2
$1.83M Sell
46,100
-2,100
-4% -$80.8K 0.01% 982
2018
Q1
$1.8M Buy
+48,200
New +$1.95M 0.01% 925

Other funds holding HOLX

Two Sigma Securities's HOLX Position: Q1 2026 in Review

Two Sigma Securities sold out of Hologic (HOLX) in Q1 2026, closing a stake of 8,228 shares — an estimated $613K sold.

Two Sigma Securities first reported a position in HOLX in Q3 2016 and held it in 19 quarters. The position peaked at $1.95M in Q2 2018. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Two Sigma Securities reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 8,228 Hologic shares in Q1 2026, an estimated $613K.
  • Two Sigma Securities first reported a position in Hologic in Q3 2016 and held it in 19 quarters.
  • Two Sigma Securities's Hologic position peaked at $1.95M in Q2 2018.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.